Status:
COMPLETED
Communication Effectiveness in Cancer Treatment
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Malignant Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
This pilot research trial studies communication effectiveness in cancer treatment. Studying how well patients and their doctors communicate about the treatment being given for cancer may help improve ...
Detailed Description
PRIMARY OBJECTIVES: I. To assess the feasibility of measuring discrepancies between patient and physician perceptions about the intent of therapy. SECONDARY OBJECTIVES: I. To explore possible corre...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with a diagnosis of cancer
- Patients must have been in active therapy for cancer for at least one month or have a scheduled surgical treatment of their cancer
- Ability to understand and the willingness to sign an institutional review board (IRB)-approved informed consent document
Exclusion
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02197091
Start Date
July 1 2014
End Date
March 1 2016
Last Update
July 3 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Comprehensive Cancer Center of Wake Forest University
Winston-Salem, North Carolina, United States, 27157